These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 31638218
1. Downregulation of miR‑143 modulates KRAS expression in colorectal carcinoma cells. Liu H, Liu J, Huo J, Li K, Li K, Guo H, Yang Y. Oncol Rep; 2019 Dec; 42(6):2759-2767. PubMed ID: 31638218 [Abstract] [Full Text] [Related]
2. Clinical and biological significance of miR-193a-3p targeted KRAS in colorectal cancer pathogenesis. Mamoori A, Wahab R, Islam F, Lee K, Vider J, Lu CT, Gopalan V, Lam AK. Hum Pathol; 2018 Jan; 71():145-156. PubMed ID: 29104111 [Abstract] [Full Text] [Related]
3. TAGLN suppresses proliferation and invasion, and induces apoptosis of colorectal carcinoma cells. Li Q, Shi R, Wang Y, Niu X. Tumour Biol; 2013 Feb; 34(1):505-13. PubMed ID: 23138394 [Abstract] [Full Text] [Related]
4. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate. Wong CC, Qian Y, Li X, Xu J, Kang W, Tong JH, To KF, Jin Y, Li W, Chen H, Go MY, Wu JL, Cheng KW, Ng SS, Sung JJ, Cai Z, Yu J. Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147 [Abstract] [Full Text] [Related]
5. Deregulation of the miR-16-KRAS axis promotes colorectal cancer. You C, Liang H, Sun W, Li J, Liu Y, Fan Q, Zhang H, Yue X, Li J, Chen X, Ba Y. Sci Rep; 2016 Nov 18; 6():37459. PubMed ID: 27857191 [Abstract] [Full Text] [Related]
6. Effect of simvastatin on cetuximab resistance in human colorectal cancer with KRAS mutations. Lee J, Lee I, Han B, Park JO, Jang J, Park C, Kang WK. J Natl Cancer Inst; 2011 Apr 20; 103(8):674-88. PubMed ID: 21398618 [Abstract] [Full Text] [Related]
7. A miR-29b Byproduct Sequence Exhibits Potent Tumor-Suppressive Activities via Inhibition of NF-κB Signaling in KRAS-Mutant Colon Cancer Cells. Inoue A, Mizushima T, Wu X, Okuzaki D, Kambara N, Ishikawa S, Wang J, Qian Y, Hirose H, Yokoyama Y, Ikeshima R, Hiraki M, Miyoshi N, Takahashi H, Haraguchi N, Hata T, Matsuda C, Doki Y, Mori M, Yamamoto H. Mol Cancer Ther; 2018 May 20; 17(5):977-987. PubMed ID: 29545333 [Abstract] [Full Text] [Related]
8. Lauric acid can improve the sensitization of Cetuximab in KRAS/BRAF mutated colorectal cancer cells by retrievable microRNA-378 expression. Weng WH, Leung WH, Pang YJ, Hsu HH. Oncol Rep; 2016 Jan 20; 35(1):107-16. PubMed ID: 26496897 [Abstract] [Full Text] [Related]
12. [The effect of RhoE on CD44 promoter and the malignant behaviors of colorectal cancer cell]. Zhou HJ, Li LL, Yue CX, Wei W, Li NJ, Tang QL, Bi F. Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Sep 20; 42(5):589-93. PubMed ID: 22007478 [Abstract] [Full Text] [Related]
16. FAM83D knockdown regulates proliferation, migration and invasion of colorectal cancer through inhibiting FBXW7/Notch-1 signalling pathway. Mu Y, Zou H, Chen B, Fan Y, Luo S. Biomed Pharmacother; 2017 Jun 20; 90():548-554. PubMed ID: 28407575 [Abstract] [Full Text] [Related]
17. Effect of deleted pancreatic cancer locus 4 gene transfection on biological behaviors of human colorectal carcinoma cells. Xiao DS, Wen JF, Li JH, Hu ZL, Zheng H, Fu CY. World J Gastroenterol; 2005 Jan 21; 11(3):348-52. PubMed ID: 15637742 [Abstract] [Full Text] [Related]
18. Pyruvate dehydrogenase kinase 4 exhibits a novel role in the activation of mutant KRAS, regulating cell growth in lung and colorectal tumour cells. Trinidad AG, Whalley N, Rowlinson R, Delpuech O, Dudley P, Rooney C, Critchlow SE. Oncogene; 2017 Nov 02; 36(44):6164-6176. PubMed ID: 28692044 [Abstract] [Full Text] [Related]
19. [Abnormal expression of APRIL in colorectal cancer cells promotes tumor growth and metastasis]. Wang GH, Lu MH, Wang JC, Wang F, Ding WF, Wang YG, Ju SQ, Wang HM. Zhonghua Zhong Liu Za Zhi; 2013 Apr 02; 35(4):249-55. PubMed ID: 23985251 [Abstract] [Full Text] [Related]
20. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1. He C, Yu T, Shi Y, Ma C, Yang W, Fang L, Sun M, Wu W, Xiao F, Guo F, Chen M, Yang H, Qian J, Cong Y, Liu Z. Gastroenterology; 2017 May 02; 152(6):1434-1448.e15. PubMed ID: 28193514 [Abstract] [Full Text] [Related] Page: [Next] [New Search]